- Report
- January 2025
- 143 Pages
Global
From €3587EUR$3,999USD£3,098GBP
- Report
- January 2025
- 143 Pages
Global
From €3587EUR$3,999USD£3,098GBP
- Report
- January 2025
- 128 Pages
Global
From €3587EUR$3,999USD£3,098GBP
- Report
- January 2025
- 133 Pages
Global
From €3587EUR$3,999USD£3,098GBP
- Report
- January 2025
- 123 Pages
Global
From €3587EUR$3,999USD£3,098GBP
- Report
- January 2025
- 134 Pages
Global
From €3587EUR$3,999USD£3,098GBP
- Report
- January 2025
- 135 Pages
Global
From €3587EUR$3,999USD£3,098GBP
- Report
- January 2025
- 135 Pages
Global
From €3587EUR$3,999USD£3,098GBP
- Report
- January 2025
- 132 Pages
Global
From €3587EUR$3,999USD£3,098GBP
- Report
- January 2025
- 134 Pages
Global
From €3587EUR$3,999USD£3,098GBP
- Report
- January 2025
- 125 Pages
Global
From €3587EUR$3,999USD£3,098GBP
- Report
- January 2025
- 130 Pages
Global
From €3587EUR$3,999USD£3,098GBP
- Report
- January 2025
- 127 Pages
Global
From €3587EUR$3,999USD£3,098GBP
- Report
- July 2024
- 125 Pages
United Kingdom
From €3587EUR$3,999USD£3,098GBP
- Report
- July 2024
- 139 Pages
United States
From €3587EUR$3,999USD£3,098GBP
- Report
- July 2024
- 134 Pages
Germany
From €3587EUR$3,999USD£3,098GBP
- Report
- July 2024
- 133 Pages
Russia
From €3587EUR$3,999USD£3,098GBP
- Report
- July 2024
- 131 Pages
China
From €3587EUR$3,999USD£3,098GBP
- Report
- July 2024
- 138 Pages
Japan
From €3587EUR$3,999USD£3,098GBP
- Report
- July 2024
- 124 Pages
Saudi Arabia
From €3587EUR$3,999USD£3,098GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more